Clinical Vignettes: 40th Annual CFS®: Innovative Cancer Therapy for Tomorrow®
Clinical Vignettes: 40th Annual CFS®: Innovative Cancer Therapy for Tomorrow® is organized by Physicians' Education Resource, LLC (PER).
Release Date: January 31, 2023
Expiration Date: January 31, 2024.
Description:
In this Clinical Vignette Series: 40th Annual CFS®: Innovative Cancer Therapy for Tomorrow®, oncology thought leaders address clinical challenges faced by community oncologists and offer their insights on the clinical application of new data and advances. This interactive, online activity features a series of case-based vignettes, self-reflection questions, and brief video clips in which the program faculty share their approaches to oncology care. This activity touches on established and emerging standards of care in multiple myeloma, as well as breast, lung, gastric, and genitourinary cancers. It is based on content presented at the 2022 CFS® meeting, an annual gathering with a long-standing history of providing education, guidance, perspectives, and solutions to practicing oncologists. Delivering state-of-the-art cancer care requires incorporation of new clinical advances and data into practice. Across all cancer types, improvements in patient outcomes are being driven by novel approaches in testing, systemic therapy, targeted therapy, and immunotherapy. This online activity provides an unparalleled opportunity to learn about these new methods for optimizing and personalizing care for your patients with cancer.
Learning Objectives:
Upon successful completion of this activity, you should be better prepared to:
• Choose the most appropriate tests to identify molecular markers and treatment targets of cancer while stratifying risk to inform clinical decision-making
• Describe key practice-changing clinical trial results that inform diagnostic and treatment approaches for hematologic malignancies and solid tumors
• Identify evidence-based immunotherapeutic, chemotherapeutic, and targeted treatments to optimize clinical outcomes
• Delineate implementation strategies for multidisciplinary teams to anticipate and proactively manage treatment-related toxicities
• Explain practice-changing evidence presented at major conferences and apply findings to optimize care.
Additional details will be posted as soon as information is available.